Neoplasia/BPH

	Prostate surgery outcomes in patients presenting with and without a urethral catheter: a long-term comparative study. World J Urol Segal N, Ehrlich Y, Lifshitz D, Darawsha AE. PMID: 42698027 [PubMed - indexed for MEDLINE]
	[Immune checkpoint inhibition plus Bacillus Calmette-Guerin (BCG) therapy in BCG-naive high-risk non-muscle-invasive bladder cancer: aÂ critical review in the context of current evidence]. Urologie Gakis G, Vom Dorp F. PMID: 42697960 [PubMed - as supplied by publisher]
	Distinct Prognostic Roles of Grade Group and Intraductal Carcinoma of the Prostate in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors. Int J Urol Ikeda J, Taniguchi H, Inoue M, Masuo Y, Nakamoto T, Taguchi M, Shimada S, Mishima T, Yanishi M, Uchida K, Kinoshita H. PMID: 42697858 [PubMed - indexed for MEDLINE]
	Reply to Francesco Di Bello, Andrea Gallioli, Joan Palou, and Alberto Breda's Letter to the Editor re: Roberto Contieri, Marco Paciotti, Alessandro Uleri et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404-12. Eur Urol Oncol Contieri R, Hurle R. PMID: 42697826 [PubMed - as supplied by publisher]
	Diagnostic accuracy of Chronic Kidney Disease Epidemiology Collaboration 2021 and Janowitz-estimated glomerular filtration rate for identifying renal dysfunction compared with 99mTc-DTPA in patients with locally advanced cervical cancer. Int J Gynecol Cancer Mora-Soto N, Viveros-Carreño D, Peralta JA, Rodríguez J, Vieira S, Varela H, Núñez M, Pareja R. PMID: 42697807 [PubMed - as supplied by publisher]
	An integrated lifestyle intervention for mitigation of adverse effects associated with androgen deprivation therapy for prostate cancer (STAMINA): a multicentre, randomised trial. Lancet Oncol Bourke L, Rosario DJ, Reale S, Ibeggazene S, Innes A, Scope A, Price G, Taylor S, Steed L, Sutton E, Stokes J, Hewison J, Morrissey D, Doherty P, Brown J, Meads D, O'Dwyer JL, Deniszczyc D, Greenfield DM, Mason M, Collinson M, Farrin A, STAMINA investigators. PMID: 42697217 [PubMed - as supplied by publisher]
	The Role of Distinct Cancer-Associated Fibroblast Subtypes in Prostate Cancer Immunotherapy. Int J Biol Sci He K, Zhao Z, Bai J, Lu T, Hu Y, He X, Wei F, Zhang Y, Gu Y, Shi Z, Meng X, Wang F, Shi C, Qin W, Zhang K, Xie Q, Yang L. PMID: 42694990 [PubMed - indexed for MEDLINE]
	Inflammatory bowel disease and prostate cancer: from epidemiological controversy to mechanistic hypotheses. Front Immunol Yu T, Zhang L, Li D, Wang Y. PMID: 42694773 [PubMed - indexed for MEDLINE]
	Urinary microbiota in bladder cancer: insights into pathogenesis, diagnosis, and therapeutic potential. Front Cell Infect Microbiol Sheng Z, Zhu J, Sun J, Zeng S, Ding J, Zhang Z. PMID: 42694772 [PubMed - indexed for MEDLINE]
	Treatment utilisation for Aboriginal and Torres Strait Islander people diagnosed with prostate cancer in Australia: a population-based study. Lancet Reg Health West Pac Yap ML, Gabriel G, Descallar J, Anderson S, Delaney GP, Do V, Murray R, Wong K, Woo HH, Griffiths K, Bennett-Brook K, Coombes J. PMID: 42694732 [PubMed]
	Nuclear Protein in Testis (NUT) Carcinoma: Diagnostic Challenges in a Patient Requiring Rescue Venovenous Extracorporeal Membrane Oxygenation. Cureus Lien IC, Bhyravabhotla K, Elsayad MM, Jani P, Dinh K. PMID: 42694693 [PubMed]
	Dietary Polyphenol Acteoside-Related Molecular Signatures in Clear Cell Renal Cell Carcinoma: Multi-Omics Profiling and Functional Validation of IMPDH1. Food Sci Nutr Chen X, Zhang D, Ji Z, Sun S, Wang J, Shen S, Zhu J. PMID: 42694600 [PubMed]
	Biomarker-guided selection of intravesical therapy in high-risk non-muscle invasive bladder cancer: A contemporary review. Ther Adv Urol Ito W, Tachibana I. PMID: 42694519 [PubMed]
	Performance of Machine Learning Models Based on Medical Imaging in Predicting Pathological Grade of Clear Cell Renal Cell Carcinoma. Cancer Med Wang Y, Song Z, Hou Z, Chen Y, Liu S, Chen C, Guan H, Pang Z, Yan S, Zhang Z, Tu R, Zhu G, Zeng X, Fan B. PMID: 42693958 [PubMed - indexed for MEDLINE]
	Real-World Effectiveness and Tolerability of Belzutifan in Sporadic Clear Cell Renal Cell Carcinoma: A Retrospective Cohort Study With Exploratory Genomic Correlation. Clin Genitourin Cancer Mathews P, Neiditz H, Hollenbeck P, Rajkumar J, Schoen MW, Pachynski RK, Knoche E. PMID: 42692965 [PubMed - as supplied by publisher]
	A Quantitative Nomogram Integrating IVIM-derived True Diffusion Coefficient and PSAD for Predicting Clinically Significant Prostate Cancer: Comparison With PI-RADS-based Assessment. Acad Radiol Wang X, Li Y, Chen Z, Shan C, Wu J, Chen Y. PMID: 42692876 [PubMed - as supplied by publisher]
	Optimizing the therapeutic ratio of PSMA-PET-guided para-aortic radiotherapy for prostate cancer: A systematic review and structured quantitative synthesis. J Med Imaging Radiat Sci Samai N, Berremdani A. PMID: 42691517 [PubMed - as supplied by publisher]
	Regional Variation in Bladder Cancer Clinical Trial Availability in the US. JAMA Netw Open Shah KU, Jaime-Casas S, Agarwal R, Zhang G, Li X, Abreu de Goes V, Castro DV, Mercier B, Simon R, Dickter S, Lau LM, Goud J, Dukkipati A, Fann J, Lau L, Lee J, Shah K, Swarat E, Zugman M, Dizman N, Moradi A, Barragan-Carrillo R, Tripathi A, Nguyen CB, Chehrazi-Raffle A, Pal SK. PMID: 42690658 [PubMed - indexed for MEDLINE]
	Value of 3D-presumed circular area ratio in MRI assessment of benign prostatic hyperplasia. World J Urol Yang J, Shi W, Xie H, Zhang Y, Li J, Guo G, Yuan M, Zou Z, Mu X. PMID: 42690423 [PubMed - indexed for MEDLINE]
	Interpretable machine learning for individualized survival prediction in node-positive, non-metastatic prostate cancer: a population-based study. Aging Male Bao E, Chai Y, Yang Y, Dai S, Wang C, Zhou X, Li X, Li Y, Yang Q, Liu J. PMID: 42690326 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 191044

Page 1 of 9553



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy